The Enterprise Value as of December 2024 (TTM) for Processa Pharmaceuticals, Inc. (PCSA) is -59865.00

According to Processa Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -59865.00. This represents a change of -103.16% compared to the average of 1.89M of the last 4 quarters.

Processa Pharmaceuticals, Inc. (PCSA) Historical Enterprise Value (quarterly & annually)

How has PCSA Enterprise Value performed in the past?

The mean historical Enterprise Value of Processa Pharmaceuticals, Inc. over the last ten years is 51.48M. The current -59865.00 Enterprise Value has changed -111.63% with respect to the historical average. Over the past ten years (40 quarters), PCSA's Enterprise Value was at its highest in in the June 2018 quarter at 169.50M. The Enterprise Value was at its lowest in in the March 2024 quarter at -2983653.95.

Processa Pharmaceuticals, Inc. (PCSA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Processa Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Processa Pharmaceuticals, Inc. (PCSA) Average Enterprise Value

How has PCSA Enterprise Value performed in the past?

The current Enterprise Value of Processa Pharmaceuticals, Inc. (PCSA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Processa Pharmaceuticals, Inc. (PCSA) Enterprise Value vs. Peers

How is PCSA’s Enterprise Value compared to its peers?

Processa Pharmaceuticals, Inc.’s Enterprise Value is less than Alpha Cognition Inc. (34.21M), less than Eupraxia Pharmaceuticals Inc. (148.17M), less than Acurx Pharmaceuticals, Inc. (8.70M), less than Fennec Pharmaceuticals Inc. (160.19M), greater than Comera Life Sciences Holdings, Inc. (-1590126.00), less than SAB Biotherapeutics, Inc. (33.37M), greater than Fresh Tracks Therapeutics, Inc. (-6447751.00), less than Third Harmonic Bio, Inc. (177.95M), less than Eliem Therapeutics, Inc. (0), less than Inhibrx Biosciences, Inc. (16.13M), greater than Merrimack Pharmaceuticals, Inc. (-10189682.00), less than Celcuity Inc. (546.48M), less than Enliven Therapeutics, Inc. (1.03B), less than AN2 Therapeutics, Inc. (6.83M), less than Miromatrix Medical Inc. (90.06M), less than Inhibikase Therapeutics, Inc. (200.81M), less than PMV Pharmaceuticals, Inc. (40.78M), less than Anebulo Pharmaceuticals, Inc. (38.79M), less than Akari Therapeutics, Plc (10.90M), less than Armata Pharmaceuticals, Inc. (195.91M), greater than Scopus BioPharma Inc. (-111950.00),

Build a custom stock screener for Processa Pharmaceuticals, Inc. (PCSA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Processa Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Processa Pharmaceuticals, Inc. (PCSA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Processa Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.